Microglia as a source and target of cytokines

GLIA - Tập 40 Số 2 - Trang 140-155 - 2002
Uwe‐Karsten Hanisch1,2
1Department of Cellular Neurosciences, Max Delbrück Center for Molecular Medicine, Berlin-Buch, Germany
2University of Applied Sciences Lausitz, Senftenberg, Germany

Tóm tắt

Abstract

Cytokines constitute a significant portion of the immuno‐ and neuromodulatory messengers that can be released by activated microglia. By virtue of potent effects on resident and invading cells, microglial cyto‐ and chemokines regulate innate defense mechanisms, help the initiation and influence the type of immune responses, participate in the recruitment of leukocytes to the CNS, and support attempts of tissue repair and recovery. Microglia can also receive cyto‐ and chemokine signals as part of auto‐ and paracrine communications with astrocytes, neurons, the endothelium, and leukocyte infiltrates. Strong responses and modulatory influences can be demonstrated, adding to the emerging view that microglial behavior is highly dependent on the (cytokine) environment and that reactions to a challenge may vary with the stimulation context. In principle, microglial activation aims at CNS protection. However, failed microglial engagement due to excessive or sustained activation could significantly contribute to acute and chronic neuropathologies. Dysregulation of microglial cytokine production could thereby promote harmful actions of the defense mechanisms, result in direct neurotoxicity, as well as disturb neural cell functions as they are sensitive to cytokine signaling. GLIA 40:140–155, 2002. © 2002 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1016/S0167-5699(00)01652-2

10.1016/S0952-7915(99)00051-5

10.1016/S0197-4580(00)00124-X

10.1111/j.1749-6632.1998.tb09548.x

10.1038/35094583

10.4049/jimmunol.159.4.1604

10.1002/glia.1106

10.1016/S0306-4522(98)00032-3

10.1038/nm1096-1074

10.1016/S0306-4522(00)00516-9

10.1016/S0166-2236(99)01453-8

10.1126/science.281.5381.1305

10.1016/S0955-0674(99)80034-9

10.1006/exnr.1999.7345

10.1002/(SICI)1098-1136(199609)18:1<11::AID-GLIA2>3.0.CO;2-6

10.1523/JNEUROSCI.16-09-02945.1996

10.1002/jemt.1121

Banks WA, 1991, Human interleukin (IL) 1 alpha, murine IL‐1 alpha and murine IL‐1 beta are transported from blood to brain in the mouse by a shared saturable mechanism, J Pharmacol Exp Ther, 259, 988

10.1016/S0165-5728(97)00103-3

10.1038/379591a0

10.1002/(SICI)1098-1136(20000215)29:4<293::AID-GLIA1>3.0.CO;2-A

10.1016/S0197-0186(01)00045-6

10.1126/science.2443979

10.1159/000125283

10.1210/edrv-17-1-64

10.1016/S0959-4388(00)00223-3

10.1038/89490

10.1002/glia.1047

10.4049/jimmunol.165.1.397

10.1046/j.1460-9568.2000.00100.x

10.1523/JNEUROSCI.13-10-04412.1993

10.1016/S0165-0173(97)00038-6

10.4049/jimmunol.163.7.3963

10.1038/12623

10.1111/j.1469-7793.1999.0585p.x

10.4049/jimmunol.151.3.1473

10.1016/0896-6273(94)90159-7

10.1523/JNEUROSCI.21-04-01179.2001

10.1074/jbc.272.4.2035

10.1016/S0169-328X(99)00034-0

10.1385/IR:21:2-3:159

10.1038/35025229

10.1038/sj.mp.4000389

Dinarello CA, 1997, Role of pro‐ and anti‐inflammatory cytokines during inflammation: experimental and clinical findings, J Biol Regul Homeost Agents, 11, 91

Dinarello CA, 1997, Blocking interleukin‐1 and tumor necrosis factor in disease, Eur Cytokine Netw, 8, 294

Dinarello CA, 1997, Induction of interleukin‐1 and interleukin‐1 receptor antagonist, Semin Oncol, 24, S9

10.3109/08830189809043005

Dinarello CA, 1998, The cytokine handbook, 35

10.1016/S0091-6749(99)70518-X

10.1016/S0306-4522(98)00407-2

10.1007/978-0-585-37970-8_8

10.1016/0306-4522(93)90380-X

10.1523/JNEUROSCI.16-08-02508.1996

10.1212/WNL.53.5.1104

10.1016/S0304-3940(00)00977-0

10.1084/jem.185.3.579

10.1016/S0166-2236(00)01674-X

10.1172/JCI119488

10.1016/0165-5728(94)90047-7

10.1002/jemt.1120

10.1016/S0166-2236(00)01617-9

10.1523/JNEUROSCI.08-02-00709.1988

10.1523/JNEUROSCI.08-07-02485.1988

10.1002/glia.440070116

10.1159/000112099

10.1016/0197-0186(94)90066-3

Giulian D, 1995, Neuroglia, 671

10.3109/13550289909029740

10.1523/JNEUROSCI.13-08-03368.1993

10.1210/en.135.6.2465

10.1016/0165-0173(95)00015-1

10.1002/(SICI)1098-2396(199610)24:2<104::AID-SYN2>3.0.CO;2-J

10.1074/jbc.272.46.28853

10.1016/S0306-4522(97)00040-7

Hanisch UK, 2001, Microglia in the degenerating and regenerating CNS, 79

Hanisch UK, 2001, Psychoneuroimmunology, 585

10.1002/1521-4141(200107)31:7<2104::AID-IMMU2104>3.0.CO;2-3

10.1073/pnas.95.18.10896

10.1016/S0079-6123(01)32114-3

10.1002/glia.1101

10.1046/j.1471-4159.2000.0750965.x

10.1126/science.290.5497.1768

10.1523/JNEUROSCI.21-06-01975.2001

10.1016/0166-2236(95)80029-2

10.1016/0014-2999(90)90099-R

10.1016/S0165-5728(00)00239-3

10.1006/clin.1997.4475

10.1016/S0166-2236(00)02088-9

10.1016/0166-2236(96)10049-7

10.1074/jbc.275.14.10308

10.4049/jimmunol.150.7.2659

10.1523/JNEUROSCI.20-14-05292.2000

10.1146/annurev.med.50.1.425

10.1016/S0165-0173(97)00037-4

10.1073/pnas.96.12.7047

10.1523/JNEUROSCI.19-11-04238.1999

10.4049/jimmunol.163.3.1628

10.1111/j.1749-6632.1998.tb09569.x

10.1016/S0165-5728(00)00295-2

10.1523/JNEUROSCI.21-18-07046.2001

10.1159/000097327

10.2174/1381612805666230111212056

10.1016/S0197-4580(01)00289-5

10.1016/S0197-4580(01)00307-4

10.1016/S0165-6147(99)01308-5

10.1016/0166-2236(96)10047-3

10.1046/j.1365-2990.1999.00200.x

10.1002/1096-9861(20010305)431:2<217::AID-CNE1066>3.0.CO;2-T

10.1073/pnas.090017497

10.1038/35050116

10.1046/j.1471-4159.2000.0751539.x

10.1093/jnen/59.6.471

10.1002/jnr.1157

10.1016/S0166-2236(00)02024-5

10.1002/glia.1108

10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G

10.1016/S0014-5793(98)00583-3

10.1111/j.1469-445X.1999.01892.x

10.1016/S0962-8924(00)01856-0

10.1038/378088a0

10.1016/S1074-7613(00)00070-4

10.1046/j.1471-4159.2000.0750576.x

10.1074/jbc.M008262200

10.1016/S0197-4580(01)00291-3

10.1002/(SICI)1097-4547(19990515)56:4<441::AID-JNR11>3.0.CO;2-G

10.1038/nm1201-1356

10.1016/S0169-328X(98)00284-8

10.1046/j.1471-4159.1999.0722215.x

10.1097/00005072-199910000-00006

10.1016/S0006-8993(01)02174-6

10.2302/kjm.45.239

10.1016/S0165-0173(99)00007-7

10.1007/978-3-7091-6391-7_4

10.1016/S0169-328X(99)00016-9

10.1016/S0197-0186(01)00040-7

10.1146/annurev.immunol.18.1.217

10.1016/0166-2236(95)93890-A

10.1038/nm0796-746

10.1038/sj.mp.4000223

10.1172/JCI119808

10.1016/S0166-2236(00)01661-1

10.4049/jimmunol.164.9.4893

10.1046/j.1471-4159.1999.721466.x

10.1038/22124

10.1073/pnas.95.13.7778

10.1111/j.1749-6632.2000.tb06346.x

10.1016/S0079-6123(08)64017-0

10.1038/sj.bjp.0701002

10.1074/jbc.275.2.1169

10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F

10.1016/S0165-5728(99)00218-0

10.4049/jimmunol.159.3.1344

10.1002/(SICI)1098-1136(20000215)29:4<355::AID-GLIA6>3.0.CO;2-4

10.1016/S0301-0082(98)00083-5

Stoll G, 2000, Cytokines in CNS disorders: neurotoxicity versus neuroprotection, J Neural Transm, 59, 81

10.1016/S0301-0082(98)00069-0

10.1002/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E

10.1016/0165-5728(94)90031-0

10.1016/S0006-8993(97)01166-9

10.1016/S0165-5728(00)00404-5

10.1152/ajpregu.1999.276.4.R1132

10.1126/science.286.5448.2352

10.1002/1521-4141(200111)31:11<3228::AID-IMMU3228>3.0.CO;2-7

10.1016/S0165-0173(99)00024-7

10.4049/jimmunol.164.5.2759

10.1016/S0378-4274(98)00318-X

Vilcek J, 1998, The cytokine handbook, 1

10.1046/j.1471-4159.2000.740457.x

Ware CF, 1998, The cytokine handbook, 549

10.1016/S0165-5728(98)00248-3

10.1016/S0169-328X(00)00069-3

10.4049/jimmunol.161.11.6368

10.1016/S1074-7613(00)00023-6

10.1038/87945

10.1046/j.1471-4159.2000.0741017.x

10.1177/135245850000600103

Zhang M, 1998, The cytokine handbook, 517

10.1016/0960-5428(96)00017-4

10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V

Thông tin
Thông tin xuất bản

GLIA

Tập 40 Số 2

140-155

Thông tin tác giả